Financials
Financial year 2025
KameleonPharma from Wellen, company number BE0666453742, closed financial year 2025 with a result of € 18,308 after tax. For that financial year KameleonPharma recorded a gross margin of € 31,928 and equity of € 57,264. Compared with financial year 2024, the result moved from € 4,836 to € 18,308. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 29, 2026.
€ 57,264
▲ 47% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 18,308
▲ 279% vs 2024
Profit after tax over the fiscal year.
€ 45,962
▲ 79% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 51,064.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
Debts at end 2025
€ 5,135
▼ 34% vs 2024
€ 2,757 is repaid this year. At this pace the long-term loan is gone in ≈ 2 years.
€ 1,150
▲ € 927 vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 6,778
▲ 28% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 16,727 | € 16,317 | € 14,713 | € 31,928 | ▲ 117% |
| Profit after taxes | € 9,141 | € 5,687 | € 4,836 | € 18,308 | ▲ 279% |
| Equity | € 28,433 | € 34,120 | € 38,957 | € 57,264 | ▲ 47% |
| Total debts | € 20,099 | € 18,556 | € 14,921 | € 13,063 | ▼ 12% |
| Cash | € 16,770 | € 12,217 | € 25,636 | € 45,962 | ▲ 79% |
| Land & buildings | € 4,217 | € 7,629 | € 7,090 | € 6,551 | ▼ 8% |
| Retained profit | € 22,233 | € 27,920 | € 32,757 | € 51,064 | ▲ 56% |
| Bank debt | € 12,799 | € 10,342 | € 7,788 | € 5,135 | ▼ 34% |
| Balance sheet total | € 48,532 | € 52,676 | € 53,878 | € 70,327 | ▲ 31% |
Key figures of KameleonPharma, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to KameleonPharma?
What happened at KameleonPharma in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 18,308 (▲ 279% vs 2024). Source: NBB ↗
- New establishment in Wellen. KBO
- Start of the company according to the CBE. KBO
In short
From € 9,141 profit in 2022 to € 18,308 profit in 2025.
Paid € 21,664 in corporate taxes since 2022.
Best year ever: 2025, with € 18,308 profit.
Management
Behind KameleonPharma is Ine Kesters.
Directors
According to the 2025 annual accounts
Ine Kesters
Director
Establishments
Establishment units
Physical locations of this company
Widdingenstraat 3
3830 Wellen
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Hosting & Email
Email provider
Self-hosted
Hosting
CLOUDFLARENET - Cloudflare, Inc., US
Website info
Features
Security
Details
- Company number
- 0666.453.742
- VAT number
- BE 0666.453.742
- Registered office
- Widdingenstraat 3, 3830 Wellen
- Names & denominations
- KameleonPharma
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 17 November 2016
- Peppol
- Active · Active since 17 Feb 2025
- Contact
- kameleonfactory.be
- Activities · NACE
Detailhandel in farmaceutische producten
Interieurontwerp
Vervaardiging van huishoudelijk en sieraardewerk
Vervaardiging van andere keramische producten
Activiteiten van interieurdecorateurs